CCM Pharmaceuticals Sdn Bhd (CCMP), a wholly-owned subsidiary of Chemical Co of Malaysia Bhd (CCM), is planning to expand its business both domestically as well as within the Association of South-East Asian Nations (Asean) region this year.
CCMP is also poised to become Malaysia’s largest pharmaceutical company in the next two years with the completion of its RM56 million second manufacturing plant in Bangi, Selangor.
CCM group managing director Dr Mohd Hashim Tajudin said the company is expected to make at least two acquisitions by the year-end involving the purchase of an equity stake in another pharmaceutical company.
source
Malaysian Medical News: keeping you up to date with news sourced from various online sites, put in one place for your convenience, with a searchable archive
No comments:
Post a Comment